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Abstract 
Background: Reliable prediction of the preoperative risk is of crucial importance for patients undergoing aortic 
repair. In this retrospective cohort study, we evaluated the metabolic equivalent of task (MET) in the preoperative risk 
assessment with clinical outcome in a cohort of consecutive patients.
Methods: Retrospective analysis of prospectively collected data in a single center unit of 296 patients undergoing 
open or endovascular aortic repair from 2009 to 2016. The patients were divided into four anatomic main groups 
(infrarenal (endo: n = 94; open: n = 88), juxta- and para-renal (open n = 84), thoraco-abdominal (open n = 13) and tho-
racic (endo: n = 11; open: n = 6). Out of these, 276 patients had a preoperative statement of their functional capacity 
in metabolic units and were evaluated concerning their postoperative outcome including survival, in-hospital mortal-
ity, postoperative complications, myocardial infarction and stroke, and the need of later cardiovascular interventions.
Results: The median follow-up of the cohort was 10.8 months. Patients with < 4MET had a higher incidence of 
diabetes mellitus (p = 0.0002), peripheral arterial disease (p < 0.0001), history of smoking (p = 0.003), obesity (p = 0.03) 
and chronic obstructive pulmonary disease (p = 0.05). Overall in-hospital mortality was 4.4% (13 patients). There was 
no significant difference in the survival between patients with a functional capacity of more than 4 MET (220 patients, 
mean survival: 74.5 months) and patients with less than 4 MET (56 patients, mean survival: 65.4 months) (p = 0.64). The 
mean survival of the infrarenal cohort (n = 169) was 74.3 months with no significant differences between both MET 
groups (> 4 MET: 131 patients, mean survival 75.5 months; < 4 MET: 38 patients, mean survival 63.6 months. p = 0.35). 
The subgroup after open surgical technique with less than 4 MET had the lowest mean survival of 38.8 months. In 
46 patients with > 4MET (20.9%) perioperative complications occurred compared to the group with < 4MET with 18 
patients (32.1%) (p = 0.075). There were no significant differences in both groups in the late cardiovascular interven-
tions (p = 0.91) and major events including stroke and myocardial infarction (p = 0.4) monitored during the follow up 
period. The risk to miss a potential need for cardiac optimization in patients > 4MET was 7%.
Conclusion: The functional preoperative evaluation by MET in patients undergoing aortic surgery is a useful sur-
rogate marker of perioperative performance but cannot be seen as a substitute for preoperative cardiopulmonary 
testing in selected individuals. Trial registration clinicaltrials.gov, registration number NCT03617601 (retrospectively 
registered).
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Introduction
For several reasons a reliable preoperative risk evaluation 
is of particular importance in vascular patients. Fore-
most the majority of indications is made for patients in 
sixth to eighth decade of their lives and a large portion of 
it remains of preventive intention such as elective aneu-
rysm repair or carotid surgery for asymptomatic occlu-
sive disease. Furthermore the presence of atherosclerotic 
disease is supposed to bear an own increased periopera-
tive risk [1, 2]. Almost 40% of all perioperative complica-
tions are made up by cardiac incidences [3]. In high-risk 
patients undergoing non-cardiac operations the 30-day 
mortality for cardiovascular death or myocardial infarc-
tion has been estimated to be over 5% [4].
A prophylactic coronary revascularization in patients 
with stable coronary artery disease by percutaneous 
coronary intervention (PCI) or bypass operation did not 
show any benefit concerning the reduction of mortal-
ity or occurrence of perioperative myocardial infarction 
when compared to medical treatment [5, 6].
The preoperative assessment of the metabolic equiva-
lent of task (MET) is an easy clinical evaluation of func-
tional capacity or exercise tolerance of an individual. A 
MET is defined as the resting metabolic rate, that is the 
amount of the consumed oxygen at rest (approximately 
3.5  ml =  02/kg/min i.e. 1.2  kcal/min for a 70  kg person) 
[7]. According to the MET concept a patient would be 
considered as “fit for surgery” when the stairs of two 
flights can be climbed and the housework can be fully 
managed by oneself. Preoperative assessment of MET 
also is used for the evaluation of the perioperative risk for 
cardiac complications.
The current guidelines of the European Society of Car-
diology and European Society of Angiology (ESC/ESA) 
restrain from preoperative cardiac testing in non-cardiac 
surgery as it has failed to improve perioperative out-
come [8]. Alike, the current guidelines of the American 
College of Cardiology and American Heart Association 
(ACC/AHA) from 2014 recommend no further cardiac 
testing in patients undergoing non-cardiac surgery with 
moderate risk for a major cardiac event (MACE) with 
a functional capacity that exceeds 4 MET with class IIb 
evidence [9]. Although these guidelines are widely sup-
ported and implemented, they are still not well validated 
for specific vascular interventions i.e. aortic operations.
In this retrospective cohort study we investigated the 
MET concept in the preoperative risk assessment with 
clinical outcome parameters in a cohort of consecutive 
patients who received open or endovascular abdominal, 
thoraco-abdominal or thoracic aortic repair. We hypoth-
esize that patients with a preoperative status of 4 MET 
and more had less perioperative complications, suf-
fered less from postoperative myocardial infarction and 
stroke and had a lower in-hospital mortality compared to 
patients with a status under 4 MET. This might support 
the recommendation of non-indicated cardiac testing in 
patients who are fit for surgery.
Methods
Patients and data collection
All relevant patients’ data were retrospectively extracted 
from the Swiss Vasc Registry, a prospective, mandatory 
nationwide computer-based vascular registry in Switzer-
land. After the extraction of the center-associated clini-
cal data all files were completed with the current patients’ 
follow-up and rechecked for obvious entry mistakes 
in the hospital software Medfolio. From May 2009 till 
March 2016, 296 patients underwent open or endovascu-
lar aortic repair and were divided into four main groups 
depending on infrarenal, juxta- and para-renal, thoraco-
abdominal and thoracic pathology (Table 1). For further 
analysis, 20 patients who underwent an emergency oper-
ation without known MET status were excluded. Beside 
demographic parameters, type of operation and urgency, 
co-morbidities and cardiovascular risk factors were doc-
umented. Perioperative data included postoperative com-
plications and reoperations, myocardial infarction and 
stroke, in-hospital mortality, and the need of later cardio-
vascular interventions.
The study was approved by the Cantonal Ethics Com-
mittee of Zurich under the Protocol Number 2017-00801 
in June 2017 and adheres to the principles of reported 
research on human beings set forth in the Helsinki Dec-
laration. The study has been registered under clinicaltri-
als.gov with the Registration Number NCT03617601.
Keywords: Metabolic equivalent of task (MET), Aortic repair, Preoperative assessment, Functional capacity
Table 1 Distribution of the four aortic intervention groups
Morphology of the four groups Open repair Endovascular n
Infrarenal 88 94 182
Juxta-/pararenal 84 0 84
Thoraco-abdominal 13 0 13
Thoracic 6 11 17
Total number 296
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Preoperative assessment
Before 2009, all patients underwent routinely a preop-
erative cardiac assessment regardless of their functional 
capacity or planned operation. Since 2009, MET concept 
was gradually adopted and more patients with > 4MET 
went for open or endovascular aortic repair without pre-
operative testing. Before 2014, the majority of patients 
underwent preoperative cardiac assessment. After the 
ACC/AHA recommendation of 2014, patients with a 
capacity > 4MET and without pathologic cardiac history 
were consequently operated without preoperative assess-
ment [9]. In case of doubt that the patients’ information 
was reliable, MET testing was done during consultation 
by the operating surgeon by completing the anamne-
sis and performing a stair climbing test. Because of the 
increased circulatory stress and the large extend of this 
procedure, all patients receiving thoraco-abdominal 
aortic repair underwent cardiac and pulmonary check-
up routinely at any time. The routine cardiac check-up 
included electrocardiogram (ECG), chest x-ray and dob-
utamine stress echocardiography (DSE) [10]. The pul-
monary evaluation included body plethysmography and 
in case of major diffusion capacity reduction a cardio-
pulmonary exercise testing (CPET). According to our 
institutional protocol every patient with atherosclerotic 
disease received single anti-aggregative treatment usually 
by Aspirin 100 mg p.o. once daily as secondary prophy-
laxis for cardiovascular events and a statin therapy, if 
not yet established previously. Furthermore, during pre-
operative anesthesiologic assessment antihypertensive 
therapy was established, if needed. All patients undergo-
ing aneurysm repair received a carotid duplex to rule out 
concomitant hemodynamically significant carotid steno-
sis in order to minimize perioperative risk for stroke.
Operative technique in open infra‑, juxta‑, 
and thoraco‑abdominal repair
All infrarenal aneurysms received preferably balloon 
occlusion of the iliac arteries in order to avoid clamping 
damage. An aneurysm was labeled juxtarenal, if at least 
one renal artery had to be clamped suprarenal in order to 
perform the proximal anastomosis. If there was suprare-
nal clamping of both renal arteries, renal cold perfusion 
was established whenever possible. In case of thoraco-
abdominal aortic repair patients were positioned in a 
right lateral decubitus position to facilitate aortic expo-
sure via thoraco-phrenico-lumbotomy. Airway manage-
ment was achieved with a double lumen endotracheal 
tube to allow unilateral right lung ventilation. Opera-
tion was performed with partial left heart bypass with 
suprainguinal cannulation of the external iliac arty and 
vein without hypothermia [11]. All patients received 
spinal cord monitoring with sensory evoked potentials 
(SEPs) and motor evoked potentials (MEPs) and prophy-
lactic spinal cord drainage and pressure monitoring prior 
to surgery [12].
Operative strategy in infrarenal and thoracic endovascular 
repair
All patients receiving endovascular repair were oper-
ated with a femoral cut-down. Indication for endovas-
cular repair was within the instructions for use (IFU) of 
the chosen endoprosthesis. Endovascular repair of aor-
tic pathologies in landing zone < 3 according to Mitchell 
and Ishimaru were operated in functional cardiac arrest 
with rapid pacing [13]. If treatment length exceeded 
20 cm and required deployment in landing zone 2, or in 
the presence of prior aortic surgery, respectively carotid-
subclavian bypass was carried out prior to endovascular 
repair in order to minimize the risk of spinal cord malp-
erfusion [14].
Follow‑up of patients
All patients with open infrarenal aortic repair had a 
duplex scan from the referring angiologist 3  months 
postoperative and clinical evaluation by the operat-
ing surgeon in order to evaluate clinical status and rule 
out incisional hernia. From then on, ultrasound and a 
physical examination was done every year. Patients with 
thoraco-abdominal open repair received an Angio-CT 
scan 3 months after surgery and then were followed with 
ultrasound. All endovascular repairs underwent postop-
erative CT scan after 3 months and one year. If sac diam-
eter was in regression and endoleaks were absent it was 
switched to an ultrasound or contrast enhanced duplex 
scan.
Statistical methods
Descriptive statistics were generated by counting and cal-
culation of percentages of the nominal and ordinal vari-
ables. Numeric variables were described with mean and 
standard deviation. Survival analysis was done according 
to the method described by Kaplan and Meier. For the 
analysis of differences between the groups the log rank 
test was used. Twenty patients out of 296 were emergen-
cies without any information about preoperative MET 
status. These patients were excluded from the compari-
son between patients with > 4MET and < 4MET according 
demographic data, survival and follow up. Perioperative 
complications, postoperative cardiac interventions and 
postoperative severe events (stroke, myocardial infarc-
tion) were calculated separately for the emergency group 
without MET status. In-hospital mortality was calculated 
for all patient regardless of their MET status focusing 
on the localization of the procedure (infrarenal, juxtare-
nal, thoraco-abdominal, thoracic). Statsdirect software 
Page 4 of 9Zientara et al. BMC Surg          (2021) 21:130 
(Version 2.7.3, Statsdirect Ltd, Cheshire, UK) was used 
for all statistical analyses.
Sensitivity/specificity analysis
Based on additional cardiac assessment we were able 
to calculate the sensitivity and specifity of the diagnos-
tic validity of MET. Sensitivity being the proportion of 
patients with a pathologic result of the assessment among 
patients with < 4MET, specificity the proportion with a 
normal result among patients with > 4MET.
Sample size calculation
Based on results of the study—power of the results of 
the retrospective risk analysis—we performed a sam-
ple size calculation. This gives us an indication of the 
number of patients needed to detect a statistically sig-
nificant difference, assuming that our hypothesis is 
true. Power: 100%—probability of not detecting the 
“true” difference. For this calculation we set the—error 
at 20%, power therefore being 80%.
Results
Demographic parameters of patients with > 4MET 
and < 4MET
Patients with < 4MET had a significant higher inci-
dence of diabetes mellitus (p = 0.0002), peripheral 
artery occlusive disease (p < 0.0001), history of smok-
ing (p = 0.003), adipositas (p = 0.03) and chronic 
obstructive pulmonary disease (p = 0.05). Further-
more, this group had a tendency to more previous car-
diovascular interventions, otherwise the two cohorts 
were comparable (Table 2). 
Follow up and survival
The median follow-up of the patients’ cohort was 
10.8  months. Mean survival of the whole cohort with 
recorded MET status (n = 276) was 74  months. There 
was no significant difference between patients with a 
functional capacity of more than 4 MET (220 patients, 
mean survival: 74.5 months) and patients with less than 4 
MET (56 patients, mean survival: 65.4 months) (p = 0.64) 
Table 2 Demographic parameters
Excluded: 20 patients with unclear METS status; 19 emergencies, 1 urgent operation
Demographic parameters METS p
 > 4 (n = 220)  < 4 (n = 56)
Age (median) (Interquartile range) 71.8 (65.0 – 77.3) 71.0 (64.5 – 76.5) 0.80
Gender (female) 30 (13.6%) 13 (23.2%) 0.09
Localisation 0.21
Infrarenal 131 (59.6%) 38 (67.9%)
Juxtarenal 61 (27.7%) 16 (28.6%)
Thoracoabdominal 13 (5.9%) 0 (0%)
Thoracic 15 (6.8%) 2 (3.6%)
Nicotine 125 (56.8%) 44 (78.6%) 0.003
Arterial hypertension 145 (65.9%) 39 (69.6%) 0.75
Diabetes (*on insuline) 13 (5.9%); (*6 (2.7%)) 11 (19.6%); (*6 (10.7%)) 0.0002
Adipositas 31 (14.1%) 31 (55.4%) 0.03
Dyslipidemia 105 (47.7%) 15 (26.8%) 0.37
Coronary artery disease 69 (31.4%) 19 (33.9%) 0.75
COPD (chronic obstructive pulmonary disease) 43 (19.5%) 18 (32.1%) 0.05
Renal insufficiency 24 (10.9%) 9 (16.1%) 0.36
Stroke 19 (8.6%) 6 (10.7%) 0.53
Myocardial infarction 22 (10%) 10 (17.9%) 0.11
Peripheral arterial occlusive disease 38 (17.3%) 25 (44.6%)  < 0.0001
Previous cardiovascular interventions* (*various procedures in 
one patient possible)
72 (32.7%) 23(41.1%) 0.24
Aortocoronary bypass operation 28 (12.7%) 8 (14.3%) 0.76
Coronary stenting 27 (12.3%) 7 (12.5%) 0.96
Valve operation 12 (5.5%) 2 (3.6%) 0.57
Aortic operation/procedure 8 (3.6%) 5 (8.9%) 0.09
Peripheral vascular operation 6 (2.7%) 4 (7.1%) 0.11
Emergency / urgent procedures 17 (7.7%) / 15 (6.8%) 3 (5.4%) / 5 (8.9%) 0.54/ 0.59
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Fig. 1 The Kaplan Meier survival curve of the whole cohort subdivided in patients with preoperative status of > 4 MET and < 4 MET
Fig. 2 The Kaplan Meier survival curve after infrarenal aortic procedure; all four subgroups (open vs endovascular, > 4MET vs < 4MET) show no 
significant differences concerning the mean survival (p = 0.82)
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(Fig.  1). The mean survival of the infrarenal cohort 
(n = 169) was 74.3 months with no significant differences 
between both MET groups (> 4 MET: 131 patients, mean 
survival 75.5 months; < 4MET: 38 patients, mean survival 
63.6 months. p = 0.35). The infrarenal cohort was subdi-
vided in four groups based on the operative technique 
(open or endovascular) and the preoperative MET status 
(> 4 or < 4 MET). The Kaplan Meier survival of all four 
subgroups shows no significant differences concerning 
the mean survival (p = 0.82) (Fig. 2). The subgroup after 
open surgical technique with less than 4 MET had the 
lowest mean survival of 38.8 months.
Perioperative complications and reoperations
In 46 patients with > 4METS (20.9%) perioperative com-
plications occurred compared to the group with < 4METS 
with 18 patients (32.1%). There was no significant differ-
ence between both groups (p = 0.075), but a slight ten-
dency for more complications in patients with < 4METS 
(32.1% vs 20.9%).
Fifty-seven complications occurred in the 46 patients 
with > 4MET. Of these 57 complications, 21 (36.8%) led 
to major reoperations and 11 (19.3%) to minor reop-
erations. Compared to the complications in the patient 
group with < 4MET, there was no significant difference 
regarding the number of major and minor reoperations 
(p = 0.89 major; p = 0.43 minor) (Table 3).
MET and late postoperative cardiovascular interventions
Sixteen percent of all patients irrespective of their func-
tional capacity underwent a cardiovascular interven-
tion after the initial hospitalization during the follow-up 
period (36 patients (16.4%) with > 4MET; 9 patients 
(16.1%) with < 4MET) without significant difference 
among the groups (p = 0.91).
MET and major events (stroke or myocardial infarction) 
after hospitalization
In the group of patients with > 4MET (220 patients), 
3.6% (8 patients) developed a myocardial infarction 
(MI) after hospitalization and 1.8% (4 patients) had a 
stroke, which results in a cumulative rate of 5.5% (12 
patients) with major events after hospitalization. Com-
pared to the group with < 4MET (56 patients), 8.9% 
(5 patients) suffered a myocardial infarction and no 
stroke. Although, there was no significant difference 
among the groups (p = 0.40), there might be a slight 
tendency to more myocardial infarction in the group 
with < 4MET.
MET and in‑hospital death
Thirteen patients out of the whole cohort (n = 296) 
died, which results in an in-hospital mortality of 
4.4% for all procedures and approaches (7 patients 
with > 4MET (3.2%), 2 patients with < 4MET (3.6%), 4 
patients with unknown MET after emergency opera-
tion (20%). In the infrarenal group of 182 patients the 
in-hospital mortality was 3.8%. Seven patients died, two 
from cardiovascular events, five from other events. Six 
of these seven patients were operated conventionally by 
laparotomy, one received an endovascular prosthesis. 
In-hospital mortality after juxtarenal approach (n = 84) 
was 4.8% (2 cardiovascular deaths, 2 other deaths). 
During follow up, there were 8 deaths in the infrarenal 
(3 cardiovascular and 5 other) and 2 deaths (both car-
diovascular) in the juxtarenal group.
In the thoraco-abdominal (n = 13) and thoracic 
approach group (n = 17) respectively, one patient died 
from cardiovascular cause, which results in an in-
hospital mortality of 7.7% and 5.9%. During follow up, 
there were no further deaths in both groups.
In the subgroup analysis of infrarenal patients there 
were no significant differences concerning in-hospi-
tal mortality with regard to preoperative MET status 
(p = 0.99).
Sensitivity of MET status for perioperative cardiovascular 
risk assessment
One hundred patients with > 4MET received con-
comitant cardiac assessment before the operation. In 
two of these patients the result of the assessment was 
unknown, while 81 showed normal results and 17 had 
pathological findings (= 98 patients with > 4MET and 
Table 3 Perioperative complications
Minor: Limb compartment, Pacemaker implantation, Perm-Cath implantation, 
Wound revision, Drainage
Major: Abdominal compartment, bleeding with re-laparotomy/re-thoracotomy, 
graft occlusion, intestinal resection
Further complications: renal insufficiency/dialysis, rhythm, endoleak (without 
therapy), bronchial infection, delirium
METS
 > 4 (n = 220)  < 4 (n = 56) p
Perioperative complications
Number of patients with complica-
tions
46 (20.9%) 18 (32.1%) 0.07
All complications (various complica-
tions per one patient included)
57 (100%)
Minor re-operation 11 (19.3%) 7 (26.9%) 0.43
Major re-operation 21 (36.8%) 10 (38.5%) 0.89
No re-operation 25 (43.9%) 9 (34.6%) 0.43
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cardiac assessment). In the group with < 4MET, 48 
patients underwent preoperative cardiac work-up. Out 
of these 36 had normal results, whereas 12 showed 
pathological results in stress echocardiography or coro-
nary angiography. Thus, sensitivity of functional capac-
ity assessment with MET was 41% with a low positive 
predictive value of 25%. In the group of > 4MET with 
preoperative cardiac work-up (n = 98), 17 patients 
showed pathological results. In 7 (7%) out of these this 
had therapeutic consequences. In the group of < 4MET 
(n = 48), 4 (8.3%) out of 12 patients received preop-
erative interventions as a result of abnormal findings. 
Thus, the risk to miss a potential need for cardiac opti-
mization in patients > 4MET was 7% (Fig. 3).
Discussion
The aim of this study was to investigate, if the preopera-
tive MET status as a functional and cost-effective param-
eter may contribute to the avoidance of unnecessary 
preoperative testing and may identify cardiovascular risk 
in indicated cases. Since there is no prospective study 
according to consequent preoperative cardiac evalua-
tion on the basis of MET status, we would like to provide 
these retrospective data as an initial starting point for 
further discussion.
In our study, 13 patients died, which resulted in an in-
hospital mortality of 4.4% for the whole cohort. In the 
infrarenal group of 182 patients the in-hospital mortal-
ity was 3.8% with no statistical difference between open 
and endovascular repair. This is consistent with those of 
major prospective studies investigating infrarenal aortic 
repair [15, 16]. This study could not demonstrate a statis-
tical difference between patients achieving more or less 
of a functional capacity of 4 MET in terms of survival and 
overall complications. The sensitivity of MET assessment 
in terms of the detecting of pathologic cardiac findings 
is with 41% quite low. This is most probably due to the 
flaw of retrospective design and the rather low sample 
size in this study. Using the figures of the EVAR 2 trial 
the 30-day mortality in the endovascular group judged 
unfit for surgery was 7.3%. The patient cohort in EVAR 
2 was categorized as unfit for surgery based on their past 
medical history of myocardial infarction, arrhythmias 
[17]. Irrespective of the operative method in our cohort 
the mortality in patients > 4MET was 4.3% and 6.1% in 
those with < 4MET. A sample size calculation taking into 
account the given numbers with a hypothesis of a better 
outcome of the > 4MET patients would claim a patients 
number of approximately 7300 patients to include into 
a prospective study, by planning the test in an one-sided 
design (i.e. > 4MET is associated with lower mortality), 
4000 patients would have to be included.
In 1999, Reilly et  al. reported that the self-reported 
exercise tolerance is a valuable tool in order to predict 
in-hospital perioperative risk [18]. We adopted the MET 
concept gradually mainly for infrarenal and juxtarenal 
aortic repair. Apart from cost reduction this regimen is 
supposed to avoid unnecessary preoperative investiga-
tions, which is claimed by current guidelines [8, 19].
The most commonly used, and a simple method to 
categorize a patients’ operative risk preoperatively is the 
ASA classification, which is easy to assess and is based 
Fig. 3 Sensitivity of MET status for perioperative cardiovascular risk assessment: All 148 patients received a preoperative cardiac assessment. The 
graph underlines the risk of missing a potential need for cardiac optimization in both MET groups.
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on the past medical history and judgement of the assess-
ing physician. This simple categorization correlates 
astonishingly well with postoperative outcome [19–21]. 
As cardiovascular morbidity is predominately expected 
in vascular patients it is not the only potential factor 
of comorbidity causing postoperative problems. For 
instance concomitant impairment of liver function in cir-
rhotic patients or chronic obstructive pulmonary disease 
(COPD) are independent risk factors for considerably 
increased postoperative mortality in general major sur-
gery [21–23]. Taking this into account it is clear that the 
surgeons intuition gives a good estimate of the periopera-
tive risk as there is evidence that the surgeons personal 
judgment on the patients’ individual risk correlates reli-
ably with postoperative outcome as well [24].
So far there have been only few reports concerning 
validity of preoperative risk assessment in non-cardiac 
surgery and none, to our knowledge, in patients under-
going aortic surgery. In patients undergoing thoracic 
surgery there is evidence that stair climbing capacity is 
a good predictor of mortality. In patients undergoing 
high-risk non-cardiac surgery the inability to climb at 
least two flights of stairs did not provide an increased 
risk of perioperative mortality but was associated with 
more cardio-pulmonary complications. However, the 
fraction was less than 10% [18, 25, 26].
In order to give valid data according to efficacy and 
safety of the functional status assessment in patients 
undergoing aortic surgery prospective data in by far 
larger numbers would be required. However, it seems 
that even in high-risk operations such as aortic sur-
gery the MET assessment of the patients gives a good 
estimate of individual physical fitness and overall 
physiological reserves as our data showed that the 
group < 4MET had a significant higher percentage of 
diabetics, claudicants and smokers. Most probably due 
to small sample sizes our data could not show any dif-
ference in mortality or cardiovascular events in patients 
with more or less than 4 MET in patients undergo-
ing aortic repair. Furthermore, the study is flawed by 
its retrospective design and the heterogeneity of data 
concerning operative technique (open or endovascu-
lar approach) and the extent of preoperative cardiac 
testing. However, since there is so far no prospective 
study evaluating the predictive quality of MET status in 
aortic surgery, the limited results could encourage the 
implementation of the MET status in further prospec-
tive trials or large registries.
Conclusion
The concept of MET analysis as a surrogate marker of 
patients’ performance in the preoperative assessment 
of patients undergoing aortic surgery does not substi-
tute cardiopulmonary testing in indicated cases as it 
failed to indicate a clear threshold for extensive preop-
erative cardiac assessment in those patients.
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